IP Library Assignment 023973/0005
Patent Assignment
Reel/Frame 023973/0005

Assignment of Assignor's Interest

Recorded: 2010-02-02 Pages: 7
Assignor
CELL GENESYS, INC.
Executed: 2009-10-14
Assignee
BIOSANTE PHARMACEUTICALS, INC.
111 BARCLAY BOULEVARD, LINCOLNSHIRE, ILLINOIS, 60069
Covered Properties (31)
Transduced Fibroblasts
Patent: 5,460,959 →
Application: 08/070,646 →
Irradiated Tumor Cell Vaccine Engineered to Express Gm-Csf
Patent: 5,637,483 →
Application: 08/265,554 →
Regulation of Systemic Immune Responses Utilizing Cytokines and Antigens
Patent: 5,904,920 →
Application: 08/486,854 →
Adenovirus Vectors Containing Heterologous Transcription Regulatory Elements and Methods of Using Same
Patent: 6,432,700 →
Application: 09/033,556 →
Adenovirus Vectors Containing Cell Status-Specific Response Elements and Methods of Use Thereof
Patent: 6,900,049 →
Application: 09/392,822 →
Publication: US 2001/0053352
Target Cell-Specific Adenoviral Vectors Containing E3 and Methods of Use Thereof
Patent: 6,495,130 →
Application: 09/474,699 →
Novel Cancer-Associated Antigens and Methods of Their Identification and Use
Patent: 7,217,421 →
Application: 09/610,891 →
Cell-Specific Adenovirus Vectors Comprising an Internal Ribosome Entry Site
Patent: 6,692,736 →
Application: 09/814,351 →
Publication: US 2003/0148520
Compositions Comprising Tissue Specific Adenoviral Vectors
Patent: 7,001,764 →
Application: 10/139,089 →
Publication: US 2003/0152553
Target Cell-Specific Adenoviral Vectors Containing E3 and Methods of Use Thereof
Patent: 6,991,935 →
Application: 10/226,820 →
Publication: US 2003/0118555
Directly Injectable Formulations Which Provide Enhanced Cryoprotection of Cell Products
Patent: 7,176,022 →
Application: 10/323,664 →
Publication: US 2004/0121300
Cytokine-expressing cellular vaccine combinations
Application: 10/404,662 →
Publication: US 2004/0197312
Compositions and Methods for Generating Multiple Polypeptides from a Single Vector Using a Virus Derived Peptide Cleavage Site, and Uses Thereof
Patent: 7,485,291 →
Application: 10/452,253 →
Publication: US 2004/0265955
Cytokine-expressing cellular vaccine combinations
Application: 10/807,449 →
Publication: US 2005/0002916
Compositions and Methods for Enhanced Expression of Immunoglobulins from a Single Vector Using a Peptide Cleavage Site
Patent: 7,498,024 →
Application: 10/831,302 →
Publication: US 2005/0003482
Compositions and Methods for Enhanced Expression of Recombinant Polypeptides from a Single Vector Using a Peptide Cleavage Site
Patent: 7,709,224 →
Application: 10/831,304 →
Publication: US 2005/0042721
Method for Treating Cancer by Vector-Mediated Delivery of One or More Anti-Angiogenic or Pro-Apoptotic Genes
Patent: 7,186,699 →
Application: 10/855,559 →
Publication: US 2005/0031593
Adenovirus Vectors Containing Cell Status-Specific Response Elements and Methods of Use Thereof
Patent: 7,575,919 →
Application: 10/938,227 →
Publication: US 2005/0169890
Aav Vector Compositions and Methods for Enhanced Expression of Immunoglobulins Using the Same
Patent: 7,714,119 →
Application: 11/179,639 →
Publication: US 2006/0034805
Addition of transgenes into adenoviral vectors
Application: 11/181,850 →
Publication: US 2006/0292682
Adenovirus vectors containing cell status-specific response elements and methods of use thereof
Application: 11/206,135 →
Publication: US 2006/0188479
Novel Cancer-Associated Antigens and Methods of Their Identification and Use
Patent: 7,226,606 →
Application: 11/274,856 →
Publication: US 2006/0078544
Directly injectable formulations which provide enhanced cryoprotection of cell products
Application: 11/484,954 →
Publication: US 2006/0251683
Methods to Express Recombinant Proteins from Lentiviral Vectors
Patent: 7,632,509 →
Application: 11/488,568 →
Publication: US 2007/0059820
Cancer Immunotherapy Compositions and Methods of Use
Patent: 7,919,079 →
Application: 11/729,339 →
Publication: US 2008/0014222
Novel Cancer-Associated Antigens and Methods of Their Identification and Use
Patent: 7,645,587 →
Application: 11/799,584 →
Publication: US 2007/0212739
Adenovirus Vectors Containing Cell Status-Specific Response Elements and Methods of Use Thereof
Patent: 7,968,333 →
Application: 11/894,776 →
Publication: US 2009/0130061
Compositions and Methods for Enhanced Expression of Recombinant Polypeptides from a Single Vector Using a Peptide Cleavage Site
Patent: 7,662,623 →
Application: 11/977,787 →
Publication: US 2008/0280356
Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
Application: 11/977,788 →
Publication: US 2010/0317096
Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site
Application: 12/220,686 →
Publication: US 2009/0270485
Adenovirus Vectors Containing Cell Status-Specific Response Elements and Methods of Use Thereof
Patent: 42,373 →
Application: 12/221,052 →
Related Assignments (23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 17, 2001
From: CALYDON, INC
To: CELL GENESYS, INC
Reel/Frame 012243/0012 →
Assignment of Assignor's Interest Sep 2, 2003
From: MOSKALENKO, MARINA; LI, BETTY; AUNG, SANDRA; PRELL, RODNEY
To: CELL GENESYS, INC.
Reel/Frame 014451/0187 →
Assignment of Assignor's Interest Sep 1, 2004
From: FANG, JIANMIN; JOOSS, KARIN; QIAN, JING-JING
To: CELL GENESYS, INC.
Reel/Frame 015749/0474 →
Assignment of Assignor's Interest Sep 2, 2004
From: JOOSS, KARIN; CRESON, JENNIFER; LI, BETTY; PRELL, RODNEY
To: CELL GENESYS, INC.
Reel/Frame 015754/0515 →
Assignment of Assignor's Interest Sep 9, 2004
From: CALYDON, INC.
To: CELL GENESYS, INC.
Reel/Frame 015822/0149 →
Assignment of Assignor's Interest Sep 9, 2004
From: YU, DE-CHAO; HENDERSON, DANIEL R.
To: CALYDON, INC.
Reel/Frame 015784/0833 →
Assignment of Assignor's Interest Oct 12, 2004
From: FANG, JIANMIN; JOOSS, KARIN; SIMMONS, ANDREW; QIAN, JING-JING
To: CELL GENESYS, INC.
Reel/Frame 015880/0780 →
Assignment of Assignor's Interest Oct 18, 2004
From: HARDING, THOMAS; JOOSS, KARIN; LALANI, ALSHAD; DONAHUE, BRIAN
To: CELL GENESYS, INC.
Reel/Frame 015893/0944 →
Assignment of Assignor's Interest Oct 26, 2005
From: FANG, JIANMIN; JOOSS, KARIN
To: CELL GENESYS, INC.
Reel/Frame 017140/0058 →
Assignment of Assignor's Interest Dec 21, 2005
From: HAWKINS, LYNDA; POLICE, SESHIDAR REDDY
To: CELL GENESYS, INC.
Reel/Frame 017384/0390 →
Assignment of Assignor's Interest Apr 29, 2008
From: QIAN, JING JING
To: CELL GENESYS, INC.
Reel/Frame 020978/0228 →
Re-Record to Correct the Docket Number on a Document Previously Recorded at Reel 020978, Frame 0228. (Assignment of Assignor's Interest) Aug 12, 2008
From: QIAN, JING JING
To: CELL GENESYS, INC.
Reel/Frame 021483/0448 →
Assignment of Assignor's Interest Dec 10, 2010
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 025470/0885 →
Assignment of Assignor's Interest Dec 22, 2010
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 025550/0722 →
Assignment of Assignor's Interest Dec 27, 2010
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 025568/0888 →
Acceptance of Patent Rights Apr 26, 2011
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 026181/0163 →
Acceptance of Patent Rights Apr 26, 2011
From: BIOSANTE PHARMACEUTICALS, INC.
To: COLD GENESYS, INC.
Reel/Frame 026180/0885 →
Assignment of Assignor's Interest Jan 31, 2013
From: BIOSANTE PHARMACEUTICALS, INC.
To: ADURO GVAX INC.
Reel/Frame 029734/0206 →
Nunc Pro Tunc Assignment Apr 26, 2017
From: BIOSANTE PHARMACEUTICALS, INC.
To: ADURO GVAX, INC.
Reel/Frame 042117/0900 →
Confirmatory License Oct 31, 2017
From: JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044327/0491 →
Change of Name Nov 9, 2020
From: COLD GENESYS, INC.
To: CG ONCOLOGY, INC.
Reel/Frame 054362/0411 →
Assignment of Assignor's Interest Jun 2, 2021
From: ADURO GVAX, INC.
To: HEALTHTREE, INC.
Reel/Frame 056416/0653 →
Assignment of Assignor's Interest Sep 3, 2021
From: CHINOOK THERAPEUTICS, INC.
To: HEALTHTREE, INC.
Reel/Frame 057385/0434 →